Arthritis Drugs Get Nod From EMA's CHMP

Tofacitinib citrate (Xeljanz), two adalimumab (Humira) biosimilars, and one methotrexate hybrid get thumbs up from EMA committee.
International Approvals

http://ift.tt/2jFRyoj